Tissue Engineering and Regenerative Medicine: Perspectives and Challenges

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Cell Therapy

Background:

• Tissue engineering and regenerative medicine have advanced significantly, offering solutions for damaged tissues and organs.
• Despite progress, few products have received regulatory approval, highlighting existing challenges.
• Key areas include cell therapy, extracellular vesicle-based therapy, and tissue engineering.

Purpose of the Study:

• To review significant advancements in cell therapy, extracellular vesicle-based therapy, and tissue engineering.
• To highlight progress in disease modeling, regenerative applications, and personalized medicine.
• To address current technical, ethical, and regulatory challenges in the field.

Main Methods:

• Review of current literature on cell therapy, extracellular vesicle-based therapy, and tissue engineering.
• Analysis of technological advancements and their applications in regenerative medicine.
• Identification of bottlenecks and challenges hindering clinical translation.

Main Results:

• Hematopoietic stem cell transplantation is effective for hematological malignancies.
• Induced pluripotent stem cells are revolutionizing disease modeling and regenerative medicine.
• Extracellular vesicles show promise in diagnostics, cell-free therapeutics, and drug delivery.
• Tissue engineering enables complex tissue construct development.

Conclusions:

• Significant progress has been made in cell therapy, extracellular vesicle-based therapy, and tissue engineering.
• Overcoming technical, ethical, and regulatory challenges requires novel technologies and interdisciplinary research.
• Standardizing practices and conducting clinical trials are crucial for balancing innovation and regulation to improve patient outcomes.